Protein transduction by pseudotyped lentivirus-like nanoparticles

Gene Therapy

Volumn 18, Issue 9, 2011, Pages 936-941

  Aoki, T ^a   Miyauchi, K ^a   Urano, E ^a   Ichikawa, R ^a   Komano, J ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

BlaM; Gag; LENA; lentiviral vector; protein transduction

Indexed keywords

BETA LACTAMASE; CELL DNA; GAG PROTEIN; NANOPARTICLE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL DIVISION; CONTROLLED STUDY; CYTOPLASM; DNA FLANKING REGION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; LENTIVIRINAE; MYRISTYLATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS; VIRUS GENOME;

CELL MOVEMENT; GENE TRANSFER TECHNIQUES; GENES, GAG; GENETIC VECTORS; HUMANS; LENTIVIRUS; NANOPARTICLES; TRANSDUCTION, GENETIC; TRANSFECTION;

LENTIVIRUS; MAMMALIA; MIRIDAE; VESICULAR STOMATITIS VIRUS;

EID: 80052564938     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2011.38     Document Type: Article

References (22)

1. MacGregor RR. Clinical protocol. A phase 1 open-label clinical trial of the safety and tolerability of single escalating doses of autologous CD4 T cells transduced with VRX496 in HIV-positive subjects. Hum Gene Ther 2001; 12: 2028-2029.
2. Cockrell AS, Kafri T. Gene delivery by lentivirus vectors. Mol Biotechnol 2007; 36: 184-204. (Pubitemid 350135911)
3. McCart JA, Bartlett DI. Lentiviral Vectors. In: Templeton NS (ed.). Gene and Cell Therapy: Therapeutic Mechanisms and Strategies, 3rd edn. CRC Press: Carrollton, 2008, pp 245-262.
4. Lundberg C, Björklund T, Carlsson T, Jakobsson J, Hantraye P, Déglon N et al. Applications of lentiviral vectors for biology and gene therapy of neurological disorders. Curr Gene Ther 2008; 8: 461-473.
5. Jacks T, Power MD, Masiarz FR, Luciw PA, Barr PJ, Varmus HE. Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature 1988; 331: 280-283. (Pubitemid 18040598)
6. Klein KC, Reed JC, Lingappa JR. Intracellular destinies: degradation, targeting, assembly, and endocytosis of HIV Gag. AIDS Rev 2007; 9: 150-161. (Pubitemid 350001486)
7. Briggs JA, Simon MN, Gross I, Kräusslich HG, Fuller SD, Vogt VM et al. The stoichiometry of Gag protein in HIV-1. Nat Struct Mol Biol 2004; 11: 672-675. (Pubitemid 38823535)
8. Wyma DJ, Jiang J, Shi J, Zhou J, Lineberger JE, Miller MD et al. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail. J Virol 2004; 78: 3429-3435. (Pubitemid 38568284)
9. Urano E, Aoki T, Futahashi Y, Murakami T, Morikawa Y, Yamamoto N et al. Substitution of the myristoylation signal of human immunodeficiency virus type 1 Pr55Gag with the phospholipase C-delta1 pleckstrin homology domain results in infectious pseudovirion production. J Gen Virol 2008; 89: 3144-3149.
10. Aoki T, Shimizu S, Urano E, Futahashi Y, Hamatake M, Tamamura H et al. Improvement of lentiviral vector-mediated gene transduction by genetic engineering of the structural protein Pr55(Gag). Gene Therapy 2010; 17: 1124-1133.
11. Voelkel C, Galla M, Maetzig T, Warlich E, Kuehle J, Zychlinski D et al. Protein transduction from retroviral Gag precursors. Proc Natl Acad Sci USA 2010; 107: 7805-7810.
12. Hubner W, Chen P, Del Portillo A, Liu Y, Gordon RE, Chen BK. Sequence of human immunodeficiency virus type 1 (HIV-1) Gag localization and oligomerization monitored with live confocal imaging of a replication-competent, fluorescently tagged HIV-1. J Virol 2007; 81: 12596-12607. (Pubitemid 350085873)
13. Campbell RE. Realization of beta-lactamase as a versatile fluorogenic reporter. Trends Biotechnol 2004; 22: 208-211. (Pubitemid 38515734)
14. Wagner R, Graf M, Bieler K, Wolf H, Grunwald T, Foley P et al. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors. Hum Gene Ther 2000; 11: 2403-2413.
15. Ulett GA, Han S, Han JS. Electroacupuncture: mechanisms and clinical application. Biol Psychiatry 1998; 44: 129-138. (Pubitemid 28305532)
16. Ford KG, Souberbielle BE, Darling D, Farzaneh F. Protein transduction: an alternative to genetic intervention? Gene Therapy 2001; 8: 1-4. (Pubitemid 32162409)
17. Zhang Y, Yu LC. Microinjection as a tool of mechanical delivery. Curr Opin Biotechnol 2008; 19: 506-510.
18. Cavrois M, De Noronha C, Greene WC. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat Biotechnol 2002; 20: 1151-1154. (Pubitemid 35285446)
19. Yamanaka S, Blau HM. Nuclear reprogramming to a pluripotent state by three approaches. Nature 2010; 465: 704-712.
20. Komano J, Miyauchi K, Matsuda Z, Yamamoto N. Inhibiting the Arp2/3 complex limits infection of both intracellular mature vaccinia virus and primate lentiviruses. Mol Biol Cell 2004; 15: 5197-5207. (Pubitemid 39564717)
21. Stauffer TP, Ahn S, Meyer T. Receptor-induced transient reduction in plasma membrane PtdIns(4,5)P2 concentration monitored in living cells. Curr Biol 1998; 8: 343-346. (Pubitemid 28159121)
22. Miyauchi K, Komano J, Yokomaku Y, Sugiura W, Yamamoto N, Matsuda Z. Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion. J Virol 2005; 79: 4720-4729. (Pubitemid 40464223)